NVCT insider buying
Every open-market purchase of Nuvectis Pharma, Inc. (NVCT) stock by its officers, directors and major shareholders, from SEC Form 4 filings.
Bought, last 12 months$1.33M
Insiders buying (12m)4
Purchases on record6
Last purchase filedJul 1, 2026
In the last 12 months, 4 insiders of Nuvectis Pharma, Inc. bought $1.33M of NVCT stock on the open market in 5 reported purchases. The most recent was filed on Jul 1, 2026: Mosseri Marlio Charles (10% Owner) bought 50,000 shares at $18.32, worth $916K. The largest purchase on record here is $957.08K by Mosseri Marlio Charles on Oct 23, 2025.
Get the next NVCT insider buy on TelegramFree daily recap of the biggest insider purchases, straight from SEC filings. Real-time alerts for Premium members.
Join free on TelegramAll NVCT insider purchases
| Filed | Insider | Value | Shares | Price | Stake | Trade | |
|---|---|---|---|---|---|---|---|
| Jul 1 | Mosseri Marlio Charles10% Owner | $916K | 50,000 | $18.32 | +2% | Jun 30 | SEC |
| Jul 1 | Bentsur RonChairman & CEO, Director, 10% Own… | $250K | 12,500 | $20.00 | +0% | Jun 30 | SEC |
| Nov 6 | Bentsur RonChairman & CEO, Director, 10% Own… | $28.60K | 5,000 | $5.72 | +0% | Nov 5 | SEC |
| Nov 6 | Sanchez JuanDirector | $75.27K | 13,000 | $5.79 | +20% | Nov 5 | SEC |
| Nov 6 | Kaplan Matthew L.Director | $64.24K | 11,000 | $5.84 | +10% | Nov 5 | SEC |
| Oct 29 | Mosseri Marlio Charles10% Owner | $957.08K | 154,770 | $6.18 | +5% | Oct 23 | SEC |